SCHEMBL22291704

SCHEMBL22291704

COc1ccc2c(-c3c(O)ccc4ccccc34)c(O)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.56
▸ CYP2A6 P11509 1/20 0.56
▸ KMT2A Q03164 5/20 0.56
▸ MAPT P10636 4/20 0.56
▸ MEN1 O00255 4/20 0.56
▸ HSP90AA1 P07900 2/20 0.50
▸ HSP90AB1 P08238 2/20 0.50
▸ STAT3 P40763 1/20 0.49
▸ ABCG2 Q9UNQ0 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ ALOX12 P18054 1/20 0.49
▸ HIF1A Q16665 1/20 0.49
▸ PHLPP2 Q6ZVD8 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ MPL P40238 1/20 0.48
▸ RRM1 P23921 1/20 0.48
▸ MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28846545 0.92 CYP1A2 (0.50) CYP1A2CYP2A6KMT2AMAPTMEN1
SCHEMBL9040087 0.84 CYP1A2 (0.72) CYP1A2CYP2A6KMT2AMAPTMEN1
SCHEMBL30267541 0.84 HSP90AA1 (0.53) CYP1A2CYP2A6KMT2AMAPTMEN1
SCHEMBL28430312 0.84 HSP90AA1 (0.53) CYP1A2CYP2A6KMT2AMAPTMEN1
SCHEMBL28628067 0.83 CYP1A2 (0.70) CYP1A2CYP2A6KMT2AMAPTMEN1
SCHEMBL1305457 0.83 KDM4E (0.50) CYP1A2CYP2A6KMT2AMAPTMEN1
SCHEMBL12473666 0.83 CYP1A2 (0.69) CYP1A2CYP2A6KMT2AMAPTMEN1
SCHEMBL12277720 0.83 CYP1A2 (0.69) CYP1A2CYP2A6KMT2AMAPTMEN1
SCHEMBL22291707 0.82 CYP1A2 (0.58) CYP1A2CYP2A6MAPTABCG2ALDH1A1
SCHEMBL6563131 0.81 MAPT (0.79) CYP1A2KMT2AMAPTMEN1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10730037-B2 Compound and method for manufacturing organic material TOYO GOSEI CO., LTD. (JP) 2020-08-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10730037-B2 Compound and method for manufacturing organic material OSTC, MAX, CAD CYP1A2 346/4885CYP2A6 761/4885KMT2A 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback